The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Size Of The Biotechnology Reagents Market Progress Through 2030?
The bipolar disorder therapeutics market size has seen strong growth recently. It is projected to increase from $7.82 billion in 2025 to $8.28 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.9%. This historical growth can be attributed to factors such as a rise in bipolar disorder diagnoses, increased awareness of mental health conditions, expanded psychiatric care services, the availability of established pharmacological treatments, and an increase in healthcare expenditure.
The bipolar disorder therapeutics market is expected to demonstrate strong expansion in the upcoming years. It is projected to climb to $10.39 billion in 2030, growing at a compound annual growth rate (CAGR) of 5.9%. This projected increase can be attributed to a rising demand for precision psychiatry solutions, the broadening of long-acting injectable therapies, increased incorporation of digital therapeutics, a heightened focus on improving treatment adherence, and greater investment in mental health research. Key trends anticipated during this period include the continued development of new mood-stabilizing therapies, an increase in the adoption of atypical antipsychotic medications, a growing emphasis on personalized mental health treatment, the expansion of combination drug therapies, and enhanced integration of digital mental health support.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7963&type=smp
What Important Drivers Are Powering The Biotechnology Reagents Market Growth?
The escalating healthcare expenditure is anticipated to fuel the expansion of the bipolar disorder therapeutics market. Healthcare expenditure encompasses all financial outlays for medical care, preventative strategies, public health initiatives, rehabilitation, community health activities, and health-related research. This rise in spending on healthcare can be attributed to several contributing factors, including an aging population, an increase in chronic diseases, and higher drug costs, all of which significantly contribute to the growing need for medical services and treatments. As awareness regarding mental health issues becomes more widespread, the diagnosis rate of bipolar disorder also climbs, subsequently leading to a greater demand for therapeutic interventions. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, total health spending in Canada is anticipated to rise by 2.8% in 2023, following a modest growth of just 1.5% in 2022. Consequently, the increasing healthcare expenditure is a key driver for the growth of the bipolar disorder therapeutics market.
What Segment Types Are Included In The Biotechnology Reagents Market Analysis?
The biotechnology reagents market covered in this report is segmented –
1) By Type: Life Science Reagents, Analytical Reagents, Other Reagents
2) By Applications: Protein synthesis And purification, Gene Expression, DNA And RNA Analysis, Drug Testing
3) By End-Users: Biotech Companies, Research Institutes, Pharmaceuticals, Diagnostic Centers, Academic Institute, Other End-Users
Subsegments:
1) By Life Science Reagents: Molecular Biology Reagents, Cell Culture Reagents, PCR Reagents, Protein Purification Reagents
2) By Analytical Reagents: Chromatography Reagents, Spectroscopy Reagents, Electrophoresis Reagents
3) By Other Reagents: Diagnostic Reagents, Biochemical Reagents, Enzyme Reagents
Which Trends Are Contributing To Changes In The Biotechnology Reagents Market?
Major companies operating in the Bipolar Disorder Therapeutics and related market are developing new treatments for depressive episodes associated with bipolar I or II disorder, aiming to reach larger customer bases, increase sales, and boost revenue. Among bipolar disorders, bipolar depression represents the most prevalent and severe clinical manifestation. Compared to manic or hypomanic episodes, these depressed episodes are linked to a poorer prognosis, longer duration, and more recurrences. For instance, in March 2024, the EDIT-B consortium, a France-based collaborative organization specializing in developing innovative diagnostic tools and biomarkers, launched myEDIT-B. This innovative blood diagnostic tool is designed to provide objective biological data that assists psychiatrists and healthcare professionals in making precise diagnoses. It analyzes RNA editing-based biomarkers and has demonstrated sensitivity and specificity rates above 80%. By facilitating quicker and more accurate diagnoses, potentially shortening the wait time to within four weeks, myEDIT-B aims to tackle the significant issue of misdiagnosis in mental health, given that around 40% of individuals diagnosed with depression may instead have bipolar disorder.
Which Firms Are Competing In The Biotechnology Reagents Market?
Major companies operating in the biotechnology reagents market are Life Technologies Corporation, Abbott Laboratories, Abcam PLC, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Company, BioLegend Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology, Danaher Corp., General Electric incorporated, Hoefer Inc., Illumina Inc., Lonza Group Ltd., Merck KGaA Group, Meridian Bioscience Inc., Millipore Corporation, New England Biolabs Inc., Novus Biologicals LLC, PerkinElmer Inc., Promega Corporation, Quality Biological Inc., Roche Holding AG, Siemens Healthineers AG, Sigma-Aldrich Corp., Sysmex Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Tosoh Corporation
Access The Complete Biotechnology Reagents Market Report:
https://www.thebusinessresearchcompany.com/report/biotechnology-reagents-global-market-report
Which Regional Market Leads The Biotechnology Reagents Market?
North America was the largest region in the biotechnology reagents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Biotechnology Reagents Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=7963&type=smp
Browse Through More Reports Similar to the Global Biotechnology Reagents Market 2026, By The Business Research Company
Molecular Biology Enzymes And Kits And Reagents Global Market Report 2026
Sequencing Reagents Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/sequencing-reagents-global-market-report
Biotech Ingredient Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
